Copyright © 2002 by the European Society of Cardiology.
Reviews
Biointerventional cardiovascular therapy
Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.
revised May 28, 2002; accepted May 29, 2002
f1 Correspondence: Dr I. D. Cox, Cardiology Division, Bulfinch 105, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, U.S.A.
References
- Oesterle SN, Reifart N, Hauptmann E, Hayase M, Yeung AC. Percutaneous in situ coronary venous arterialization: report of the first human catheter-based coronary artery bypass. Circulation. 2001;103:25392543
[Abstract/Free Full Text] - Oesterle SN, Sanborn TA, Ali N. Percutaneous transmyocardial laser revascularization for severe angina: the PACIFIC randomized trial. Lancet. 2000;356:17051710[CrossRef][Web of Science][Medline]
- Simons M, Bonow RO, Chronos NA. Clinical trials in coronary angiogenesis: Issues, problems, consensus: An expert panel summary. Circulation. 2000;102:E73
- Isner JM. Myocardial gene therapy. Nature. 2002;415:234239[CrossRef][Medline]
- Barr E, Carroll J, Kalynych AM. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther. 1994;1:5158[Web of Science][Medline]
- Boekstegers P, von Degenfeld G, Giehrl W. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins. Gene Ther. 2000;7:232240[CrossRef][Web of Science][Medline]
- Li JJ, Ueno H, Pan Y. Percutaneous transluminal gene transfer into canine myocardium in vivo by replication-defective adenovirus. Cardiovasc Res. 1995;30:97105[CrossRef][Web of Science][Medline]
- Vale PR, Losordo DW, Tkebuchava T, Chen D, Milliken CE, Isner JM. Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping. J Am Coll Cardiol. 1999;34:246254
[Abstract/Free Full Text] - Sanborn TA, Hackett NR, Lee LY. Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance. Catheter Cardiovasc Interv. 2001;52:260266[CrossRef][Web of Science][Medline]
- Vale PR, Losordo DW, Milliken CE. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation. 2001;103:21382143
[Abstract/Free Full Text] - von der Leyen HE, Gibbons GH, Morishita R. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA. 1995;92:11371141
[Abstract/Free Full Text] - Kutryk MJ, Foley DP, van den Brand M. Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trial. J Am Coll Cardiol. 2002;39:281287
[Abstract/Free Full Text] - Kipshidze N, Moses J, Shankar LR, Leon M. Perspectives on antisense therapy for the prevention of restenosis. Curr Opin Mol Ther. 2001;3:265277[Web of Science][Medline]
- Shah AS, Lilly RE, Kypson AP. Intracoronary adenovirus-mediated delivery and overexpression of the beta 2-adrenergic receptor in the heart: prospects for molecular ventricular assistance. Circulation. 2000;101:408414
[Abstract/Free Full Text] - Weig HJ, Laugwitz KL, Moretti A. Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors In vivo by ultrasound-guided injection or transcoronary delivery. Circulation. 2000;101:15781585
[Abstract/Free Full Text] - Miyamoto MI, del Monte F, Schmidt U. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci USA. 2000;97:793798
[Abstract/Free Full Text] - Koh GY, Klug MG, Soonpaa MH, Field LJ. Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest. 1993;92:15481554[Web of Science][Medline]
- Soonpaa MH, Koh GY, Klug MG, Field LJ. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science. 1994;264:98101
[Abstract/Free Full Text] - Leor J, Patterson M, Quinones MJ, Kedes LH, Kloner RA. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? Circulation. 1996;94:II3326
- Scorsin M, Hagege AA, Marotte F. Does transplantation of cardiomyocytes improve function of infarcted myocardium? Circulation. 1997;96:II18893
- Li RK, Mickle DA, Weisel RD. Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation. 1997;96:II17986
- Taylor DA, Atkins BZ, Hungspreugs P. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 1998;4:929933[CrossRef][Web of Science][Medline]
- Scorsin M, Hagege A, Vilquin JT. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg. 2000;119:11691175
[Abstract/Free Full Text] - Tomita S, Li RK, Weisel RD. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 1999;100:II24756
- Anversa P, Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature. 2002;415:240243[CrossRef][Medline]
- Orlic D, Kajstura J, Jakoniuk I. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701705[CrossRef][Medline]
- Kocher A, Schuster M, Takuma S. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling, and improves cardiac function. Nat Med. 2001;7:430436[CrossRef][Web of Science][Medline]
- Menasche P, Hagege A, Scorsin M. Autologous skeletal myoblast transplantation for cardiac insufficiency. First clinical case. Arch Mal Coeur Vaiss. 2001;94:180182[Web of Science][Medline]
- Thompson CA, Nasseri BA, Makower J. Percutaneous transvenous cellular cardiomyoplasty: a novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol. 2002;39:75A
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||